From June 19th to 21st, Space Peptides Pharmaceutical Co., Ltd.(referred to as “Space Peptides”) participated in the 22nd CPHI China 2024, attracting the attention of many industries with its unique AI new drug discovery technology and one-stop service achievements from peptide innovation drug research and development to industrial production. Dr.Runze HE, founder and CEO of Space Peptides, led the team to have in-depth communication and exchanges with partners from all over the world at booth (E2A10).
As the most influential pharmaceutical raw material exhibition in Asia, CPHI China 2024 brings together the world’s top pharmaceutical companies and professionals. On this international stage, Space Peptides demonstrated the strength and style of Chinese pharmaceutical companies to the world with its cutting-edge technology and outstanding innovation.
At this exhibition, Space Peptides introduced VR technology, combined with large LED screens, to provide customers with an immersive technological experience. Through VR glasses, delve into the Chemical Space peptide drug molecular database of Space Peptides and intuitively experience the powerful application of AI technology in drug screening. This molecular library has strong logicality, which can help scientists quickly and accurately to find peptide molecules with better drug properties. Through thinking ahead half-life, toxicity and other drug development parameters, it reduces the risk of new drug research and development, greatly reducing research and development costs and cycles.
In addition, Space Peptides highlighted the latest research and development achievements in the fields of AI and new drug screening and peptide innovation drugs, as well as the innovative capabilities and strong strength of its subsidiaries in chemical CRO, pre-clinical research, and large-scale production. Through communication and presentation at the booth, we have successfully attracted the attention of numerous potential partners and reached multiple strategic cooperation intentions. These collaborations will provide more resources and opportunities for the future development of Space Peptides and further driving the company’s breakthroughs and growth in the peptide field.
